L'Oreal Says Ozempic Era Is Denting Skin Care Sales
L'Oreal CEO Nicolas Hieronimus says GLP-1 weight loss drugs are hitting skin care sales, as the company designs products for rapid-weight-loss side effects.
Topic
Glp 1 Medications
Topic
Topic
Topic
L'Oreal CEO Nicolas Hieronimus says GLP-1 weight loss drugs are hitting skin care sales, as the company designs products for rapid-weight-loss side effects.